Korean ODM Launch Timeline: 6 Months From Brief to First Shipment (Founder Playbook 2026)

TL;DR

A new-formula launch with a Korean ODM typically runs 18 to 26 weeks from signed brief to a pallet leaving Incheon, and another 2 to 4 weeks of US import handling before product is sellable on your site. If you re-use an existing formula (private label or shelf-formula ODM), the same arc collapses to 6 to 10 weeks to ship-ready inventory. Most first-time founders price the calendar at the optimistic end and get caught on three slip points: sample-round churn, packaging-tooling lead time, and MOCRA-related labeling rework. This playbook walks the realistic timeline, where the slip points sit, and what to lock early so the calendar holds.

Why founders mis-price the calendar

The cost spreadsheet usually goes through three revisions before launch. The calendar usually goes through one. That asymmetry is the single biggest reason indie launches show up to retail meetings without product.

Two structural reasons it happens:

First, sample rounds are not estimable from the outside. Industry references (OEMKorea, Style Story, Sourcing Lab, and several Korean ODM-aggregator platforms) cite 8 to 16 weeks for ODM new-formula development and 16 to 24 weeks for complex claims - that range exists because sample iteration count is the actual gating variable, not lab throughput. A formula that gets approved on round two ships in week 16. A formula with claim substantiation requirements that hits round five ships in week 22.

Second, US-side regulatory work (MOCRA facility registration, product listing, label compliance review under 21 CFR Parts 700-740) usually runs in parallel with manufacturing but only if the founder starts it on day one. If it starts after the first pilot batch - which is the default for founders who don't know the timeline shape - it adds 3 to 5 weeks to the back end. The FDA's biennial facility registration renewal cycle, updated through the Cosmetics Direct portal in early 2026, doesn't change the on-ramp work; new product listings still need to be submitted before US distribution.

The playbook below assumes a new-formula launch, single SKU, 5,000-10,000 unit first batch, US-bound. It compresses cleanly for private label and stretches for multi-SKU launches.

The 6-Month Timeline, Week by Week

Weeks 1-2: Brief lock + ODM matching

What happens: NDA, briefing call, target-cost band, target retail price, ingredient must-haves and must-nots, packaging direction, claim direction, target launch month. ODM shortlist of two to four labs based on fit (active expertise, MOQ tolerance, line capacity).

What founders underestimate: the brief is the most expensive document in the launch. A change to the actives panel in week 8 costs roughly the same as a change in week 2 - except in week 8, you're paying for sample rounds you've already done. Lock the actives, the texture target, and the regulatory market list (US-only? US + EU? US + UK?) before kickoff.

Common slip cause: founder discovers in week 3 that their preferred packaging vendor's tooling lead time is 10 weeks. Calendar restarts.

Weeks 3-6: Sample rounds + formulation

What happens: ODM lab develops 1st sample (base formula + active blend), founder evaluates blind alongside reference products, requests adjustments (texture, scent, color, slip, after-feel, active concentration within label-claim range). Round two follows in 10-14 days; round three if needed.

What founders underestimate: decision time on the founder side is part of the lab's calendar. A sample sitting on a kitchen counter for nine days because the founder is traveling adds nine days to the ship date. ODMs cannot start the next round until they have your decision.

Common slip cause: too many people in the approval loop. Indie launches with a single decision-maker compress the sample phase by 20-40%.

Weeks 7-10: Final sample approval + packaging chain lock

What happens: Final formula approved (signed sample retention pack), packaging spec frozen, secondary packaging artwork begins, primary container PO placed, label artwork drafted against the locked formula + market regulatory requirements.

What founders underestimate: packaging is the second timeline, running on its own clock. Custom airless pumps, custom dropper assemblies, and custom jar shapes can require 8-14 weeks of tooling time even after artwork is approved. If you've designed a custom bottle, that decision needed to be made in week 1, not week 7.

Common slip cause: artwork revisions. A label rework after the first proof typically adds 1-2 weeks; a re-color or material change adds 4-6.

Weeks 11-14: Pilot batch + stability testing kickoff

What happens: ODM runs a pilot batch (usually 50-200 kg) under production conditions. Pilot is split: one portion goes into accelerated stability chambers, another into real-time chambers, retention samples are archived, and remaining product is used for compatibility testing with the chosen primary container.

What the stability work actually looks like: Korean ODM labs commonly reference ICH Q1A(R2) accelerated conditions - 40°C ± 2°C / 75% RH ± 5%, with sampling at months 0, 3, and 6. That standard originates in pharma but is widely adopted in cosmetics; full accelerated stability runs 6 months. For a launch that needs to ship sooner, many labs will release product after the 3-month accelerated checkpoint if month-0 and month-3 sit within acceptance bands for pH, viscosity, microbial count (ISO 17516), and organoleptic stability - with the understanding that the 6-month checkpoint completes after launch.

Common slip cause: a pilot batch that misses a stability gate (typically pH drift or viscosity drift at month 3) and forces a formula tweak + re-pilot. Adds 4-8 weeks.

Weeks 15-20: Production batch + remaining stability work

What happens: First production batch runs on the locked formula and packaging. Filling, capping, labeling, secondary pack assembly, QC release. Real-time stability continues in parallel and follows the product post-launch.

What founders underestimate: line scheduling is not first-come-first-served at most ODMs. Larger clients book line time in quarterly windows. An indie 5,000-unit batch that needs to slot into a line booked by a 200,000-unit client gets the next gap - which can be 2-4 weeks out. Booking the production slot at week 8, contingent on sample approval, holds the calendar.

Common slip cause: secondary packaging components (cartons, inserts, shipper boxes) arriving late from a separate vendor and idling a fully-filled batch in the ODM's warehouse, accruing storage fees.

Weeks 21-26: US regulatory close-out, export, customs, warehouse

What happens: MOCRA facility registration confirmed (if not already), product listing submitted via Cosmetics Direct, US labeling reviewed against 21 CFR Part 701, adverse-event reporting setup live at a US address, freight booked (typically ocean LCL/FCL from Incheon to LA/LB or NY/NJ; air freight only for tight launches due to cost). US customs broker handles entry; FDA may issue a "May Proceed" or hold for review. Warehouse receives and counts. Listing live on the brand's own site.

What founders underestimate: MOCRA was the back-end work nobody wanted to think about until 2024, and it is now front-end work. The FDA's biennial registration renewal cycle, updated in early 2026, means founders who registered a facility in 2024 are renewing this year. New brands registering for the first time should treat MOCRA setup as week-1 work, not week-22 work.

Common slip cause: importer-of-record confusion. The Responsible Person under MOCRA must be a US-based entity. For founders launching from a non-US holding structure, this needs to be clarified before the first shipment leaves Korea.

Where the timeline actually slips (and how to pre-empt)

Three slip points compound across the 6 months:

1. Sample-round count. Plan for three rounds; budget for four. The single highest-leverage pre-empt is a 90-minute briefing call where the founder, the lab cosmetic chemist, and (if applicable) the brand's perfumer/sensory consultant align on what "approved" looks like. Aligning on the after-feel and the scent direction at the start removes 60-70% of the round-three rework I've seen across indie launches.

2. Packaging tooling lead time. Custom primary containers are the second-most-common slip cause after sample-round churn. If the launch calendar is tight, default to stock primary packaging with custom labeling and custom secondary. Stock pumps, droppers, and jars from major Korean and Chinese suppliers ship in 2-4 weeks; custom tooling can run 10-14 weeks.

3. MOCRA / US labeling rework. Label artwork that was designed before the formula was final almost always gets re-set. Build the label artwork in weeks 8-10, after the active concentrations and the INCI list are locked. A label re-set on a printed carton run is expensive and adds 2-4 weeks.

A short pre-empt list that holds the calendar:

• Week 1: Lock the regulatory market list. US only is fastest; EU + US doubles the dossier work.

• Week 1: Brief the packaging vendor in parallel with the ODM brief.

• Week 1: Begin MOCRA facility registration (or confirm the ODM's existing US-registered facility covers the product).

• Week 3: Confirm production line slot, contingent on sample approval.

• Week 8: Begin label artwork against the locked formula.

• Week 14: Confirm freight broker + US importer of record.

Founder Note

A line I repeat to first-time founders in NYC: the calendar isn't the constraint, the decision velocity is. The Korean labs we work with at altameet move fast - three sample rounds in seven weeks is normal, not aggressive - but they cannot move faster than the founder's approval cadence. The brands that hit a 18-week new-formula launch are not the brands with the most resources. They're the brands with one decision-maker, a locked brief, and the discipline to evaluate samples within 72 hours of receipt.

We sit on both sides of that conversation from our Manhattan office - translating the brand's vision into Korean ODM-readable spec, and translating the lab's constraints back into language a founder can decide on. The 6-month timeline is the median. The 4-month timeline exists. It's a function of preparation, not luck.

Liz Song, altameet

What now (3 next steps)

1. Map your launch month to a brief-lock date. If your retail launch target is November 2026, your brief needs to be signed by mid-May at the latest for a new-formula path, or mid-July for a shelf-formula path.

2. Pull a 1-page sample-approval rubric before the first sample arrives. We send one to every altameet client.

3. Book a 15-minute intro call if you want a second opinion on whether your timeline is realistic - partnerships@altameet.com or the contact form below.

FAQ

Q: Can a Korean ODM launch ship in 12 weeks?

Yes, with a shelf-formula (private label or lightly modified existing base), stock primary packaging, custom labeling only, and a single SKU. Most "fast launch" timelines published online assume this path without flagging it.

Q: Does stability testing have to finish before launch?

Not always. Many indie launches ship after the 3-month accelerated stability checkpoint (per ICH Q1A(R2) sampling intervals) with real-time stability continuing post-launch. The 6-month accelerated point becomes a release-confirmation gate, not a launch gate.

Q: What's the realistic MOQ for a 6-month new-formula timeline?

Most Korean ODMs working with indie founders quote 1,000-3,000 units as a flexible-MOQ floor for a new-formula run; some specialist labs will go to 500 for a strategic fit. Below 1,000 units, the per-unit plant cost typically pushes retail price above the brand's target band.

Q: Where does the calendar break for multi-SKU launches?

The bottleneck shifts from formulation (which can run in parallel) to packaging tooling and label-artwork QC, both of which scale linearly with SKU count. A 3-SKU launch on the same actives platform adds approximately 4-6 weeks; a 3-SKU launch on three separate formulations adds 8-12 weeks.

Q: Can I do MOCRA registration after the first batch is made?

Technically yes, before US distribution begins. Practically: starting MOCRA setup on day one (or confirming the ODM's facility registration covers the product) avoids a 3-5 week back-end delay before product can be sold in the US.

References

• ICH Q1A(R2) - Stability Testing of New Drug Substances and Products (accelerated conditions: 40°C ± 2°C / 75% RH ± 5%, sampling at 0, 3, 6 months)

• ISO 17516:2014 - Cosmetics - Microbiology - Microbiological limits

• 21 CFR Parts 700-740 - FDA cosmetic labeling regulations

• FDA MoCRA Final Guidance (December 2024) - Registration and Listing of Cosmetic Product Facilities and Products

• FDA Cosmetics Direct portal updates (early 2026) - biennial facility registration renewal